Variant report
Variant | nsv965786 |
---|---|
Chromosome Location | chr6:167112978-167114881 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537699569 | chr6:167113024-167113025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549681691 | chr6:167113038-167113039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570884208 | chr6:167113041-167113042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571490045 | chr6:167113064-167113065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538814084 | chr6:167113074-167113075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538277714 | chr6:167113178-167113179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138699915 | chr6:167113185-167113186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373216861 | chr6:167113190-167113191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149545274 | chr6:167113191-167113192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs16900973 | chr6:167113245-167113246 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs144105714 | chr6:167113272-167113273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544093003 | chr6:167113315-167113316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369341660 | chr6:167113328-167113329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373071765 | chr6:167113339-167113340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559314295 | chr6:167113417-167113418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577287822 | chr6:167113448-167113449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182085309 | chr6:167113450-167113451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559785178 | chr6:167113480-167113481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140527519 | chr6:167113510-167113511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536651004 | chr6:167113549-167113550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542310374 | chr6:167113557-167113558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560876785 | chr6:167113564-167113565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555340489 | chr6:167113600-167113601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112207784 | chr6:167113675-167113676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549644851 | chr6:167113685-167113686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191914046 | chr6:167113691-167113692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531973681 | chr6:167113716-167113717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553269584 | chr6:167113730-167113731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144360480 | chr6:167113763-167113764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577937333 | chr6:167113780-167113781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535927993 | chr6:167113842-167113843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6934715 | chr6:167113843-167113844 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs570233627 | chr6:167113941-167113942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373453473 | chr6:167113968-167113969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565102391 | chr6:167113969-167113970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76052771 | chr6:167113979-167113980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539107212 | chr6:167113980-167113981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537668237 | chr6:167113981-167113982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533077686 | chr6:167113988-167113989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183299953 | chr6:167113989-167113990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186651259 | chr6:167113992-167113993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377483860 | chr6:167114010-167114011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541410930 | chr6:167114026-167114027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551289030 | chr6:167114033-167114034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111411049 | chr6:167114048-167114049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6911624 | chr6:167114049-167114050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542699896 | chr6:167114060-167114061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541932273 | chr6:167114108-167114109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563471616 | chr6:167114173-167114174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6913194 | chr6:167114181-167114182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167102200-167116000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:167102200-167116600 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr6:167102200-167117600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr6:167106000-167113000 | Weak transcription | Stomach Smooth Muscle | stomach |
5 | chr6:167109200-167117000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr6:167112600-167113800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:167112800-167115200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
8 | chr6:167112800-167116600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:167113600-167115200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr6:167113600-167115200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr6:167114000-167114800 | Enhancers | Primary hematopoietic stem cells | blood |
12 | chr6:167114000-167115000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |